Canadian Imperial Bank of Commerce
CM
Bank of Nova Scotia
BNS
Royal Bank of Canada
RY
The Toronto-Dominion Bank
TD
Bank of Montreal
BMO
CA Stock MarketDetailed Quotes
CTX Crescita Therapeutics Inc
- 0.560
- +0.040+7.69%
15min DelayMarket Closed Mar 21 16:00 ET
10.71MMarket Cap-4.00P/E (TTM)
0.560High0.560Low1.00KVolume0.560Open0.520Pre Close560.00Turnover0.69052wk High0.01%Turnover Ratio19.12MShares0.40552wk Low-0.14EPS TTM9.36MFloat Cap2.000Historical HighLossP/E (Static)16.71MShs Float0.350Historical Low-0.14EPS LYR0.00%Amplitude--Dividend TTM0.68P/B1Lot Size--Div YieldTTM
Crescita Therapeutics Inc Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 31.26%2.73M | 627.20%1.38M | 239.20%424K | 575.31%547K | -82.26%378K | 303.53%2.08M | 88.22%-261K | -72.59%125K | 1.25%81K | 223.37%2.13M |
| Net income from continuing operations | -38.47%-2.75M | -8.00%-162K | 19.19%-1.04M | -229.54%-926K | -129.30%-626K | -330.39%-1.99M | -112.73%-150K | -757.44%-1.28M | -659.46%-281K | 42.41%-273K |
| Operating gains losses | -1,450.00%-81K | -740.00%-64K | -166.67%-24K | ---2K | 80.00%9K | -96.59%6K | -80.39%10K | -1,000.00%-9K | ---- | -58.33%5K |
| Depreciation and amortization | -9.30%1.37M | -3.69%365K | -17.24%312K | -18.93%304K | 2.67%385K | 2.38%1.51M | 0.53%379K | 5.31%377K | 1.35%375K | 2.46%375K |
| Asset impairment expenditure | -41.10%258K | -64.56%56K | -52.78%51K | -37.21%81K | 62.79%70K | -16.73%438K | -12.71%158K | -36.47%108K | 12.17%129K | -28.33%43K |
| Remuneration paid in stock | 120.73%181K | 180.95%17K | 456.25%89K | -16.92%54K | -4.55%21K | -62.90%82K | -143.75%-21K | -23.81%16K | -14.47%65K | -71.05%22K |
| Deferred tax | -103.07%-14K | -107.11%-14K | --0 | --0 | --0 | 199.56%456K | 143.01%197K | --0 | --93K | --166K |
| Other non cashItems | 37.61%-146K | 142.68%67K | 123.53%12K | -328.57%-48K | -276.60%-177K | -127.18%-234K | 15.14%-157K | -466.67%-51K | 310.00%21K | -146.53%-47K |
| Change In working capital | 116.32%3.91M | 264.11%1.11M | 5.59%1.02M | 437.69%1.08M | -62.17%696K | 148.67%1.81M | 80.13%-677K | 445.00%966K | 41.21%-321K | 255.21%1.84M |
| -Change in receivables | -59.63%1.48M | -61.97%-230K | -23.88%1.04M | 140.04%1.28M | -131.30%-601K | 250.45%3.67M | 94.08%-142K | 2,822.00%1.36M | 547.06%532K | 1,423.81%1.92M |
| -Change in inventory | 336.97%2.17M | 613.45%2.02M | -35.92%-912K | 6,700.00%66K | 568.46%996K | 48.48%-917K | 52.87%-394K | -195.59%-671K | 98.94%-1K | 123.92%149K |
| -Change in payables and accrued expense | 135.33%430K | -115.98%-730K | 109.20%887K | 92.52%-75K | 216.00%348K | -624.57%-1.22M | -24.72%-338K | 1,866.67%424K | -177.84%-1M | -133.78%-300K |
| -Change in other current assets | -164.21%-174K | -75.63%48K | 106.08%9K | -221.85%-184K | -166.20%-47K | -0.73%271K | 103.09%197K | -804.76%-148K | 439.29%151K | -44.09%71K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 31.26%2.73M | 627.20%1.38M | 239.20%424K | 575.31%547K | -82.26%378K | 303.53%2.08M | 88.22%-261K | -72.59%125K | 1.25%81K | 223.37%2.13M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,418.05%-2.02M | -236.19%-353K | -2,592.86%-754K | -912K | 0 | 54.14%-133K | -41.89%-105K | -1,300.00%-28K | 0 | 0 |
| Net PPE purchase and sale | -732.33%-1.11M | -236.19%-353K | -2,592.86%-754K | ---912K | --0 | 41.92%-133K | -707.69%-105K | -1,300.00%-28K | --0 | --0 |
| Net other investing changes | ---912K | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,418.05%-2.02M | -236.19%-353K | -2,592.86%-754K | ---912K | --0 | 54.14%-133K | -41.89%-105K | -1,300.00%-28K | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -10.10%-861K | 6.98%-240K | 29.94%-227K | -56.44%-158K | -138.38%-236K | 57.64%-782K | -16.74%-258K | -19.12%-324K | 91.48%-101K | 41.07%-99K |
| Net issuance payments of debt | -8.09%-441K | -7.62%-113K | -6.80%-110K | -8.91%-110K | -9.09%-108K | 70.28%-408K | -6.06%-105K | -11.96%-103K | 90.74%-101K | -8.79%-99K |
| Net common stock issuance | 18.58%-320K | 49.67%-77K | 51.25%-117K | ---48K | ---78K | 8.39%-393K | -112.50%-153K | -33.33%-240K | --0 | --0 |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | ---- | ---- | 216.67%19K | --0 | --19K | ---- | ---- |
| Net other financing activities | ---100K | ---50K | ---- | ---- | ---50K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -10.10%-861K | 6.98%-240K | 29.94%-227K | -56.44%-158K | -138.38%-236K | 57.64%-782K | -16.74%-258K | -19.12%-324K | 91.48%-101K | 41.07%-99K |
| Net cash flow | ||||||||||
| Beginning cash position | 13.92%9.39M | -15.80%8.44M | -11.87%9.01M | -7.24%9.53M | 13.92%9.39M | -27.30%8.24M | -6.68%10.02M | -2.63%10.23M | -12.49%10.28M | -27.30%8.24M |
| Current changes in cash | -113.35%-155K | 225.48%783K | -145.37%-557K | -2,515.00%-523K | -93.01%142K | 136.79%1.16M | 75.14%-624K | -224.73%-227K | 98.43%-20K | 355.61%2.03M |
| Effect of exchange rate changes | 407.14%43K | 533.33%52K | -177.27%-17K | 113.79%4K | -20.00%4K | -122.22%-14K | -220.00%-12K | -59.26%22K | -185.29%-29K | 114.29%5K |
| End cash Position | -1.19%9.27M | -1.19%9.27M | -15.80%8.44M | -11.87%9.01M | -7.24%9.53M | 13.92%9.39M | 13.92%9.39M | -6.68%10.02M | -2.63%10.23M | -12.49%10.28M |
| Free cash from | -20.74%1.54M | 379.51%1.02M | -520.62%-408K | -550.62%-365K | -82.26%378K | 255.56%1.94M | 83.57%-366K | -78.63%97K | 191.01%81K | 247.07%2.13M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Big Five Big Five
The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.